David A. Siegel Teva Pharmaceutical Industries LTD Transaction History
Two Sigma Advisers, LP
- $47 Billion
- Q3 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Two Sigma Advisers, LP holds 187,400 shares of TEVA stock, worth $4.76 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
187,400
Previous 232,100
19.26%
Holding current value
$4.76 Million
Previous $3.89 Million
2.67%
% of portfolio
0.01%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding TEVA
# of Institutions
673Shares Held
616MCall Options Held
30.8MPut Options Held
18.5M-
Black Rock Inc. New York, NY43MShares$1.09 Billion0.02% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L341.3MShares$1.05 Billion10.51% of portfolio
-
Menora Mivtachim Holdings Ltd.38.9MShares$989 Million4.08% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.37.7MShares$958 Million6.84% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.32.6MShares$828 Million7.09% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $28.2B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...